Bevacizumab ELISA (mAb-based)
Enzyme immunoassay for the specific and quantitative determination of free Bevacizumab (Avastin) in serum and plasma.
The solid phase (MTP) is coated by a highly specific monoclonal antibody directed against Bevacizumab. Therefore any cross reactivity to the other therapeutical monoclonal antibodies, even with its 5 pointmutation Fab counterpart (Ranibizumab) is excluded.
Intended Use: This kit has been developed for the measurement of drug levels in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.
Quality Control Certificates
Avastin® is a trademark of Genentech Inc./Roche.
The Kit at a glance:
|Required Volume (µL)||10|
|Incubation Time (min)||100|
|Sample||Serum or Plasma|
|Package Size||96 Tests|
|Standard Range (µg/mL, 1000x)||0-200|
|Detection Limit (ng/mL)||5|
|Spike Recovery (%)||>95%|
|Shelf Life (years)||2|